Roberto Testi
TitleCited byYear
Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis
C Giordano, G Stassi, R De Maria, M Todaro, P Richiusa, G Papoff, ...
Science 275 (5302), 960-963, 1997
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase.
MG Cifone, R De Maria, P Roncaioli, MR Rippo, M Azuma, LL Lanier, ...
Journal of Experimental Medicine 180 (4), 1547-1552, 1994
The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells
R Testi, D D'Ambrosio, R De Maria, A Santoni
Immunology today 15 (10), 479-483, 1994
Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule.
LL Lanier, R Testi, J Bindl, JH Phillips
Journal of Experimental Medicine 169 (6), 2233-2238, 1989
Requirement for GD3 ganglioside in CD95-and ceramide-induced apoptosis
R De Maria, L Lenti, F Malisan, F d'Agostino, B Tomassini, A Zeuner, ...
Science 277 (5332), 1652-1655, 1997
Multiple pathways originate at the Fas/APO‐1 (CD95) receptor: sequential involvement of phosphatidylcholine‐specific phospholipase C and acidic sphingomyelinase in theá…
MG Cifone, P Roncaioli, R De Maria, G Camarda, A Santoni, G Ruberti, ...
The EMBO journal 14 (23), 5859-5868, 1995
T cell activation via Leu-23 (CD69)
R Testi, JH Phillips, LL Lanier
The Journal of Immunology 143 (4), 1123, 1989
Nitric oxide primes pancreatic β cells for Fas-mediated destruction in insulin-dependent diabetes mellitus
G Stassi, R De Maria, G Trucco, W Rudert, R Testi, A Galluzzo, ...
Journal of experimental medicine 186 (8), 1193-1200, 1997
Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++á…
R Testi, JH Phillips, LL Lanier
The Journal of Immunology 142 (6), 1854-1860, 1989
Sphingomyelin breakdown and cell fate
R Testi
Trends in biochemical sciences 21 (12), 468-471, 1996
Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.
I Cascino, G Papoff, R De Maria, R Testi, G Ruberti
The Journal of Immunology 156 (1), 13-17, 1996
Caspases mediate retinoic acid–induced degradation of the acute promyelocytic leukemia PML/RARα fusion protein
C Nervi, FF Ferrara, M Fanelli, MR Rippo, B Tomassini, PF Ferrucci, ...
Blood 92 (7), 2244-2251, 1998
Src kinase phosphorylates Caspase‐8 on Tyr380: a novel mechanism of apoptosis suppression
S Cursi, A Rufini, V Stagni, I Cond˛, V Matafora, A Bachi, AP Bonifazi, ...
The EMBO journal 25 (9), 1895-1905, 2006
Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors
R De Maria, MG Cifone, R Trotta, MR Rippo, C Festuccia, A Santoni, ...
Journal of Experimental Medicine 180 (5), 1999, 1994
GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion
The FASEB Journal 14 (13), 2047-2054, 2000
Involvement of p21ras activation in T cell CD69 expression
D d'Ambrosio, DA Cantrell, L Frati, A Santoni, R Testi
European journal of immunology 24 (3), 616-620, 1994
Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity
R De Maria, R Testi
Immunology today 19 (3), 121-125, 1998
Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells
R De Maria, MR Rippo, EH Schuchman, R Testi
Journal of Experimental Medicine 187 (6), 897-902, 1998
Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis.
M Boirivant, R Pica, R DeMaria, R Testi, F Pallone, W Strober
The Journal of clinical investigation 98 (11), 2616-2622, 1996
Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation.
R De Maria, M Boirivant, MG Cifone, P Roncaioli, M Hahne, J Tschopp, ...
The Journal of clinical investigation 97 (2), 316-322, 1996
The system can't perform the operation now. Try again later.
Articles 1–20